LATEST MANUSCRIPTS IN Neuropsychiatric Disease and Treatment
Min Gao, Wenhua Sang, Kun Mi, Jiancong Liu, Yudong Liu, Wenge Zhen, Bang An. The Relationship Between Theta Power, Theta Asymmetry and the Effect of Escitalopram in the Treatment of Depression.Neuropsychiatric disease and treatment. 2023, 19: 2241-2249
Jing Zhao, Dandan Wang, Xinmin Liu, Yu Wang, Xingquan Zhao. The Predictive Value of Essen and SPI-II on the Risk of 5-Year Recurrence in Chinese Patients with Acute Ischemic Stroke.Neuropsychiatric disease and treatment. 2023, 19: 2251-2260
Yue Wu, Zhiqun Mao, Fengwei Cui, Jie Fan, Zhouling Yuan, Li Tang. Neurocognitive Characteristics of Subjective Cognitive Decline and Its Association with Objective Cognition, Negative Emotion, and Sleep Quality in Chinese Elderly.Neuropsychiatric disease and treatment. 2023, 19: 2261-2270
Caner Yeşiloğlu, Lut Tamam, Mehmet Emin Demirkol, Zeynep Namlı, Mahmut Onur Karaytuğ. Associations Between the Suicidal Ideation and the Tolerance for Psychological Pain and Tolerance for Physical Pain in Patients Diagnosed with Major Depressive Disorder.Neuropsychiatric disease and treatment. 2023, 19: 2283-2294
Zhenlei Peng, Qiyu Jia, Junxiong Mao, Qizhong Yi. Effects of Combined Therapy of Olanzapine and Samidorphan on Safety and Metabolic Parameters in Schizophrenia Patients: A Meta-Analysis.Neuropsychiatric disease and treatment. 2023, 19: 2295-2308
Luyu Zhan, Huimin Yin, Yujun Gao, Yi Li, Jun Ma. Prevalence and Factors Associated with Subclinical Hypothyroidism in Major Depressive Disorder Patients with Dyslipidemia.Neuropsychiatric disease and treatment. 2023, 19: 2309-2318
Zhizhuan Guo, Wenwen Zhong, Zhengshou Zou. miR-98-5p Prevents Hippocampal Neurons from Oxidative Stress and Apoptosis by Targeting STAT3 in Epilepsy in vitro.Neuropsychiatric disease and treatment. 2023, 19: 2319-2329
Zhijie Chen, Tao Lin, Da Liu, Yongqin Zeng, Xubiao Zhang, Bin Deng, Dongliang Guo, Tao Shi, Ming Lu. Comparison of Short-Term Surgery Outcomes and Clinical Characteristics Between Elderly and Non-Elderly Patients with Middle Third Parasagittal and Parafalcine Meningiomas.Neuropsychiatric disease and treatment. 2023, 19: 2331-2340
Ning Li, Jia Zhang, Si-Jia Li, Yang Du, Qi Zhou, Hong-Qiu Gu, Xing-Quan Zhao. Multidimensional Outcomes of IV Thrombolysis in Minor Ischemic Stroke: Motor, Psychocognitive, and Dependence.Neuropsychiatric disease and treatment. 2023, 19: 2341-2351
Carlo E Sotelo-Ramírez, Beatriz Camarena, Marco Antonio Sanabrais-Jiménez, Julio Uriel Zaragoza-Hoyos, Bruno Ordoñez-Martínez, Raul I Escamilla-Orozco, Beatriz Gómez-González. Toll-Like Receptor () , and Gene Polymorphisms Support Evidence of Innate Immune Factors in Schizophrenia.Neuropsychiatric disease and treatment. 2023, 19: 2353-2361
Hua-Song Shentu, Yi-Hua Chen, Zhen-Yu Cheng, Bin Fu, Yuan-Hao Fu, Shu-Feng Zheng, Chan Li. A Prospective Cohort Study of Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 as a Serologic Marker in Relation to Severity and Functional Outcome of Acute Intracerebral Hemorrhage.Neuropsychiatric disease and treatment. 2023, 19: 2363-2379
Cheng Huang, Peiming Zhang, Yu Dong, Ruchun Chang, Jinxiong Lao, Ziyong Li, Danchun Lan. A Meta-Analysis on the Efficacy of Acupuncture as an Adjuvant Therapy for Schizophrenia.Neuropsychiatric disease and treatment. 2023, 19: 2381-2400
Masaki Kato, Toshiaki Kikuchi, Koichiro Watanabe, Tomiki Sumiyoshi, Yoshiya Moriguchi, Daniel Oudin Åström, Michael Cronquist Christensen. Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population.Neuropsychiatric disease and treatment. 2023, 19: 2401-2412